Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055702
Filing Date
2024-05-08
Accepted
2024-05-08 16:17:45
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arct-20240331.htm   iXBRL 10-Q 1100570
2 EX-10.33 arct-ex10_33.htm EX-10.33 108547
3 EX-31.1 arct-ex31_1.htm EX-31.1 14967
4 EX-31.2 arct-ex31_2.htm EX-31.2 14925
5 EX-32.1 arct-ex32_1.htm EX-32.1 8243
6 EX-32.2 arct-ex32_2.htm EX-32.2 8212
7 GRAPHIC img267161004_0.jpg GRAPHIC 21592
8 GRAPHIC img267161004_1.jpg GRAPHIC 90057
9 GRAPHIC img267161004_2.jpg GRAPHIC 86993
  Complete submission text file 0000950170-24-055702.txt   5809909

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT arct-20240331.xsd EX-101.SCH 1097337
60 EXTRACTED XBRL INSTANCE DOCUMENT arct-20240331_htm.xml XML 599981
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38942 | Film No.: 24926356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)